本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

20.21
-0.1200-0.59%
成交量:33.75万
成交额:686.18万
市值:25.57亿
市盈率:56.43
高:20.58
开:20.06
低:20.06
收:20.33
52周最高:35.72
52周最低:16.10
股本:1.27亿
流通股本:7,811.99万
量比:0.55
换手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):0.3581
每股收益(LYR):-1.5970
净资产收益率:14.10%
总资产收益率:5.13%
市净率:6.37
市盈率(LYR):-12.65

数据加载中...

2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities